ASH Oral Presentation Details:

Event    68th ASH Annual Meeting and Exposition, New Orleans, LA
Title    "45-patient safety and efficacy data for NXC-201 from Nexicart-2, the first U.S. trial of CAR-T in relapsed/refractory AL amyloidosis"
Presentation

Date/Time (Central Time)    
Publication #826
Session Date: Monday, December 14, 2026
Session Name: 652. MGUS, Amyloidosis, and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological: Advancing Treatment Strategies in AL Amyloidosis
Session Time: 10:30 AM -12:00 PM
Presentation Time: 11:15 AM

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.